85 related articles for article (PubMed ID: 3447702)
1. [Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
Schiavoni G; Bosimini E; Amico C
Cardiologia; 1987 Nov; 32(11):1293-6. PubMed ID: 3447702
[No Abstract] [Full Text] [Related]
2. [Ergometric evaluation of slow-release isosorbide-5-mononitrate in exertional angina with stable threshold].
Fazzini PF; Pucci P
Cardiologia; 1987 Nov; 32(11):1297-302. PubMed ID: 3447703
[No Abstract] [Full Text] [Related]
3. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
[TBL] [Abstract][Full Text] [Related]
4. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
5. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
6. [The anti-anginal efficacy of the drug forms of isosorbide-5-mononitrate--Monocinque, Monocinque retard and isosorbide dinitrate].
Chernov SA; Tiurin VP; Gospodarenko AL; Kutepov IuS; Virs EA; Malenik OM
Voen Med Zh; 1997 Apr; 318(4):39-41. PubMed ID: 9221593
[No Abstract] [Full Text] [Related]
7. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
[TBL] [Abstract][Full Text] [Related]
8. Mononitrates as monotherapy in the prophylactic treatment of angina pectoris.
Rehnqvist N; Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Ulvenstam G; Aberg A; Aström H
Drugs; 1987; 33 Suppl 4():100-3. PubMed ID: 3622313
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
10. Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
Bidoggia H
Curr Med Res Opin; 1987; 10(9):601-11. PubMed ID: 3325229
[TBL] [Abstract][Full Text] [Related]
11. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
12. [Clinical use of slow-release isosorbide-5-mononitrate in cardiac insufficiency].
Caponnetto S; Canale C; Terrachini V; Masperone MA
Cardiologia; 1987 Nov; 32(11):1303-9. PubMed ID: 3447704
[No Abstract] [Full Text] [Related]
13. Long-acting isosorbide mononitrate.
Prakash A; Markham A
Drugs; 1999 Jan; 57(1):93-9; discussion 100. PubMed ID: 9951954
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
15. Extended-release isosorbide mononitrate for angina.
Med Lett Drugs Ther; 1994 Feb; 36(915):13-4. PubMed ID: 8283957
[No Abstract] [Full Text] [Related]
16. Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.
Meffert M; Paeckelmann IM
Drugs; 1987; 33 Suppl 4():104-10. PubMed ID: 3622314
[TBL] [Abstract][Full Text] [Related]
17. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
Jansen W; Geppert R; Weidmann B; Tauchert M
Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
[No Abstract] [Full Text] [Related]
18. Is isosorbide mononitrate better than the dinitrate?
Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
[No Abstract] [Full Text] [Related]
19. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
Uberbacher HJ; Glocke M; Abshagen U
MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
[No Abstract] [Full Text] [Related]
20. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
[Next] [New Search]